The study protocol consisted of an invasive collateral flow index ( CFI ) measurement immediately before intracoronary injection of 40 microg of GM-CSF ( n = 10 ) or placebo ( n = 11 ) and after a 2-week period with subcutaneous GM-CSF ( 10 microg/kg ) or placebo , respectively .
